Comment on: "A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention Deficit/Hyperactivity Disorder".

CNS Drugs

Department of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.

Published: December 2022

Download full-text PDF	Source
http://dx.doi.org/10.1007/s40263-022-00966-6	DOI Listing

Publication Analysis

comment phase

phase iii

iii randomized

randomized double-blind

double-blind placebo-controlled

placebo-controlled trial

trial assessing

assessing efficacy

efficacy safety

safety viloxazine

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!